V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 270017210 | 270018563 | 1.67 | null | Curative (C) | null | 2016-01-15 | Carboplatin + Etoposide iv&po | null | N | 270025145 | CARBOPLATIN + CETUXIMAB + FU |
| 270017211 | 270014995 | 180 | 93.1 | Curative (C) | 2015-02-20 | 2015-02-20 | Cetuximab + CISPLATIN + FLUOROURACIL | 2 | N | 270025188 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 270017212 | 270010704 | 1.58 | 63 | Palliative (P) | 2014-06-09 | 2014-07-08 | FOCUS4 TRIAL | N | N | 270025206 | CAPECITABINE + MITOMYCIN |
| 270017213 | 270014997 | 1.73 | 77 | Curative (C) | 2015-12-03 | 2015-12-06 | Ralitrexed | 2 | null | 270025272 | CHLORAMBUCIL |
| 270017214 | 270010709 | 1.62 | 58 | Palliative (P) | 2018-03-06 | 2018-03-06 | Cetuximab +Cisplatin + FU (Cycle 1) | N | null | 270025294 | CABAZITAXEL |
| 270017215 | 270014999 | 1.84 | 94 | Curative (C) | 2014-04-24 | 2014-05-07 | Capecitabine (14 days)+Carboplatin | N | N | 270025344 | CAP + RT |
| 270017216 | 270010712 | 1.47 | 59.4 | null | 2013-11-23 | 2013-11-24 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN | 2 | N | 270025395 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 270017217 | 270010713 | 1.82 | 66.3 | null | 2014-06-03 | 2014-06-18 | BLEOMYCIN | 2 | null | 270025433 | CARBOPLATIN + CETUXIMAB + FU |
| 270017218 | 270010714 | 1.48 | null | Palliative (P) | 2018-06-13 | 2018-07-26 | ETOPOSIDE | N | null | 270025491 | CETUXIMAB + CISPLATIN + FLUOROURACIL |
| 270017219 | 270010715 | 1.68 | 89.9 | Adjuvant (A) | 2017-05-17 | 2017-05-17 | GEMCITABINE + VINORELBINE | 2 | N | 270025495 | BREVITY TRIAL |
| 270017220 | 270010716 | 1.63 | 59 | Disease modification (D) | 2019-08-12 | 2019-08-12 | Fluorouracil + Folinic + RT Bossett | 02 | N | 270025562 | CARBO + FLUOROURACIL |
| 270017221 | 270010719 | 1.76 | 89 | Palliative (P) | 2016-08-09 | 2016-08-09 | Cisplatin + Etoposide po&iv 3 day | 02 | N | 270025622 | CARBOPLATIN + CETUXIMAB + FU |
| 270017222 | 270017280 | 1.78 | 66.2 | Palliative (P) | 2015-04-17 | 2015-04-20 | LENALIDOMIDE | 02 | N | 270025663 | CISPLATIN + GEMCITABINE + RITUXIMAB |
| 270017223 | 270010722 | 1.72 | 71.2 | Adjuvant (A) | 2016-04-16 | 2016-10-13 | Docetaxel | N | N | 270025707 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 270017224 | 270010723 | 1.61 | null | Curative (C) | 2017-07-18 | 2017-08-22 | Docetaxel 75mg/m2 (21 day) | N | N | 270025740 | CARBOPLATIN + DOCETAXEL + FLUOROURACIL |
| 270017225 | 270015009 | 1.71 | 119.4 | null | 2017-09-24 | 2017-09-30 | Cisplatin + Vinorelbine (IV) | 02 | N | 270025795 | CARBO + FLUOROURACIL |
| 270017226 | 270010726 | 1.88 | 76.4 | Palliative (P) | 2015-11-13 | 2015-11-29 | Docetaxel | N | N | 270025827 | OXALIPLATIN + MDG + PANITUMUMAB |
| 270017227 | 270010727 | null | 91.6 | Palliative (P) | 2015-02-14 | 2015-02-14 | Cetuximab+Cisplatin+FU (> Cycle 2) | null | N | 270025840 | CISPLATIN + FLUOROURACIL + RT |
| 270017228 | 270010730 | 1.84 | 83.8 | Curative (C) | 2016-11-25 | 2016-11-26 | Carbo F | 2 | N | 270025857 | BEVACIZUMAB + CAPE + OXALIPLATIN |
| 270017229 | 270010732 | 1.94 | 63 | null | 2018-04-02 | 2018-04-07 | Cetuximab + CISPLATIN + FLUOROURACIL | 02 | N | 270025859 | CARBOPLATIN + CETUXIMAB + FU |
| 270017230 | 270010734 | null | 86 | Adjuvant (A) | 2017-12-22 | 2018-01-19 | OXALIPLATIN | 02 | N | 270025878 | CAPECITABINE + CARBOPLATIN |
| 270017231 | 270010737 | 1.62 | 79 | Curative (C) | 2017-07-15 | 2017-07-21 | IBRUTINIB | 2 | null | 270000003 | CHLORAMBUCIL |
| 270017232 | 270010740 | null | 67 | Curative (C) | 2017-05-07 | 2017-05-09 | Capecitabine + Mitomycin | N | N | 270000307 | PAZOPANIB |
| 270017233 | 270010744 | null | 80.2 | Palliative (P) | 2014-08-16 | 2016-02-18 | CARBOPLATIN + PACLITAXEL | N | N | 270000882 | CISPLATIN + FLUOROURACIL + RT |
| 270017234 | 270010747 | 1.69 | null | Curative (C) | 2018-06-02 | 2018-06-02 | Cetuximab+Cisplatin+FU (> Cycle 2) | 02 | N | 270001351 | BEVACIZUMAB + CAPECITABINE |
| 270017235 | 270010751 | 1.82 | null | Curative (C) | 2017-12-21 | 2018-01-11 | ICE (no GCSF) | 02 | N | 270001661 | BREVITY TRIAL |
| 270017236 | 270019309 | 1.83 | 109 | Palliative (P) | 2018-11-25 | 2018-11-25 | RATHL TRIAL | N | N | 270002435 | METHOTREXATE INTRATHECAL |
| 270017237 | 270010754 | 1.75 | 106 | Curative (C) | null | 2017-04-14 | PEMBROLIZUMAB | N | N | 270002550 | DOCETAXEL |
| 270017238 | 270015018 | 1.57 | 74.6 | Palliative (P) | 2015-12-02 | 2016-01-03 | IVA | N | N | 270002563 | CAPECITABINE + CETUXIMAB + IRINOTECAN |
| 270017239 | 270010756 | null | 79.2 | Palliative (P) | 2011-09-21 | 2014-04-18 | CHLVPP PABLOE | N | N | 270002807 | ECHELON 1 TRIAL |
| 270017240 | 270010761 | 1.76 | 62 | Palliative (P) | 2017-05-19 | 2017-05-19 | FOXTROT TRIAL | N | N | 270003718 | DOCETAXEL |
| 270017241 | 270010765 | 1.7 | null | Palliative (P) | 2018-01-26 | 2018-01-26 | Bortezomib + MELPHALAN | null | N | 270004101 | CARBOPLATIN + ETOPOSIDE |
| 270017242 | 270010768 | null | 89.9 | Palliative (P) | 2017-06-27 | 2017-06-27 | CARBOPLATIN + Cetuximab + FLUOROURACIL | 02 | N | 270004490 | BEVACIZUMAB + IRINOTECAN + MDG |
| 270017243 | 270010771 | null | 49 | Palliative (P) | 2015-07-05 | 2015-07-06 | Pemetrexed | N | N | 270004767 | CAPECITABINE + CISPLATIN |
| 270017244 | 270010774 | 1.7 | 80.6 | Curative (C) | 2018-10-21 | 2018-11-06 | CARBO + FLUOROURACIL | 02 | N | 270004836 | CARBOPLATIN + ETOPOSIDE |
| 270017245 | 270010777 | 1.77 | 62 | Neo-adjuvant (N) | 2019-02-06 | 2019-02-07 | FLUOROURACIL + MITOMYCIN + RT | 02 | null | 270004923 | IBRUTINIB |
| 270017246 | 270015025 | 1.94 | 79.9 | Palliative (P) | 2017-03-07 | 2017-03-13 | Cetuximab + CISPLATIN + FLUOROURACIL | N | N | 270004960 | IRINOTECAN + RALTITREXED |
| 270017247 | 270010779 | 1.58 | 84 | Curative (C) | 2014-01-08 | 2014-01-08 | GemCarbo Days 1+8 | 99 | null | 270005126 | AFLIBERCEPT |
| 270017248 | 270010780 | null | null | Disease modification (D) | 2018-09-27 | 2018-10-06 | Aflibercept + CAPECITABINE + IRINOTECAN | N | N | 270005171 | AFLIBERCEPT |
| 270017249 | 270017292 | null | 83 | Not known (9) | 2018-07-23 | 2018-08-20 | LENALIDOMIDE | N | N | 270005171 | COPP |
| 270017250 | 270010781 | 0 | 84.6 | Palliative (P) | 2019-01-08 | 2019-01-10 | Docetaxel 75mg/m2 (21 day) | 02 | N | 270005477 | CARBOPLATIN + PACLITAXEL |
| 270017251 | 270010785 | 1.81 | 86.8 | null | 2018-11-20 | 2018-11-21 | Paclitaxel 80mg/m2 day 1 8 15 | N | N | 270005991 | CARBOPLATIN + RT |
| 270017252 | 270010786 | 1.76 | null | Palliative (P) | 2018-03-07 | 2018-03-27 | Carbo F | null | N | 270006156 | CETUXIMAB + CISPLATIN + FU |
| 270017253 | 270017293 | 1.64 | 58.2 | Curative (C) | 2018-01-27 | 2018-01-28 | Cabazitaxel | N | N | 270006274 | CARBOPLATIN + CETUXIMAB + FU |
| 270017254 | 270010791 | null | 53.9 | Palliative (P) | null | 2016-01-25 | SCOT TRIAL | null | N | 270006324 | OXALIPLATIN |
| 270017255 | 270010793 | 1.56 | 63 | Disease modification (D) | 2016-01-14 | 2016-03-15 | Carbo F | N | N | 270006621 | PEMETREXED |
| 270017256 | 270010795 | 1.72 | 80 | null | 2017-11-30 | 2017-11-30 | DOXORUBICIN | 2 | N | 270006717 | BEVACIZUMAB + IRINOTECAN + MDG |
| 270017257 | 270010796 | 1.75 | 79 | Curative (C) | 2017-05-31 | 2017-06-03 | Methotrexate intrathecal | N | N | 270007266 | CYCLOPHOSPHAMIDE |
| 270017258 | 270010796 | 1.74 | 83.9 | Palliative (P) | 2014-04-10 | 2014-04-11 | CISPLATIN + DOCETAXEL + FLUOROURACIL | 2 | N | 270007266 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 270017259 | 270010797 | 1.6 | 92 | Palliative (P) | 2017-07-27 | 2017-07-28 | CAPECITABINE + CARBOPLATIN + Cetuximab | N | N | 270007970 | CARBOPLATIN + CETUXIMAB + FLUOROURACIL |